Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-03-17

Clinical Trial Update: A CCTA Guided Management Strategy Versus a Standard of Care Strategy in Type 2 NSTEMI

View source ↗

Summary

This clinical trial comparing CCTA-guided management versus standard of care in Type 2 non-ST-elevation myocardial infarction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Louisville | Conditions: Myocardial Injury | Status: WITHDRAWN